• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 20 年单机构局限性前列腺癌根治性前列腺切除术的结果。

Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China.

机构信息

Division of Urology, Department of Surgery, The University of Hong Kong, Hong Kong, China.

Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

Asian J Androl. 2023 May-Jun;25(3):345-349. doi: 10.4103/aja202264.

DOI:10.4103/aja202264
PMID:36124535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10226499/
Abstract

The long-term survival outcomes of radical prostatectomy (RP) in Chinese prostate cancer (PCa) patients are poorly understood. We conducted a single-center, retrospective analysis of patients undergoing RP to study the prognostic value of pathological and surgical information. From April 1998 to February 2022, 782 patients undergoing RP at Queen Mary Hospital of The University of Hong Kong (Hong Kong, China) were included in our study. Multivariable Cox regression analysis and Kaplan-Meier analysis with stratification were performed. The 5-year, 10-year, and 15-year overall survival (OS) rates were 96.6%, 86.8%, and 70.6%, respectively, while the 5-year, 10-year, and 15-year PCa-specific survival (PSS) rates were 99.7%, 98.6%, and 97.8%, respectively. Surgical International Society of Urological Pathology PCa grades (ISUP Grade Group) ≥4 was significantly associated with poorer PSS (hazard ratio [HR] = 8.52, 95% confidence interval [CI]: 1.42-51.25, P = 0.02). Pathological T3 stage was not significantly associated with PSS or OS in our cohort. Lymph node invasion and extracapsular extension might be associated with worse PSS (HR = 20.30, 95% CI: 1.22-336.38, P = 0.04; and HR = 7.29, 95% CI: 1.22-43.64, P = 0.03, respectively). Different surgical approaches (open, laparoscopic, or robotic-assisted) had similar outcomes in terms of PSS and OS. In conclusion, we report the longest timespan follow-up of Chinese PCa patients after RP with different approaches.

摘要

根治性前列腺切除术(RP)治疗中国前列腺癌(PCa)患者的长期生存结果尚不清楚。我们对接受 RP 治疗的患者进行了单中心回顾性分析,以研究病理和手术信息的预后价值。1998 年 4 月至 2022 年 2 月,共有 782 例在香港大学玛丽医院(中国香港)接受 RP 的患者纳入我们的研究。进行多变量 Cox 回归分析和 Kaplan-Meier 分析及分层。5 年、10 年和 15 年的总生存率(OS)分别为 96.6%、86.8%和 70.6%,5 年、10 年和 15 年的 PCa 特异性生存率(PSS)分别为 99.7%、98.6%和 97.8%。国际泌尿病理协会前列腺癌分级(ISUP 分级组)≥4 与较差的 PSS 显著相关(风险比 [HR] = 8.52,95%置信区间 [CI]:1.42-51.25,P = 0.02)。病理 T3 期在本队列中与 PSS 或 OS 无显著相关性。淋巴结侵犯和包膜外侵犯可能与较差的 PSS 相关(HR = 20.30,95%CI:1.22-336.38,P = 0.04;和 HR = 7.29,95%CI:1.22-43.64,P = 0.03)。不同的手术方式(开放、腹腔镜或机器人辅助)在 PSS 和 OS 方面的结果相似。总之,我们报告了不同手术方式治疗中国 PCa 患者 RP 后最长时间的随访结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10226499/d2c3b101b88a/AJA-25-345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10226499/d2c3b101b88a/AJA-25-345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/10226499/d2c3b101b88a/AJA-25-345-g001.jpg

相似文献

1
Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China.中国 20 年单机构局限性前列腺癌根治性前列腺切除术的结果。
Asian J Androl. 2023 May-Jun;25(3):345-349. doi: 10.4103/aja202264.
2
The influence of prostate volume on pathological outcomes after radical prostatectomy: A single-center retrospective study.前列腺体积对根治性前列腺切除术后病理结果的影响:单中心回顾性研究。
Medicine (Baltimore). 2023 Dec 8;102(49):e36526. doi: 10.1097/MD.0000000000036526.
3
Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.代谢综合征对潜在适合主动监测的低危前列腺癌队列行根治性前列腺切除术的围手术期和肿瘤学结局的影响。
Eur Urol Focus. 2019 May;5(3):425-432. doi: 10.1016/j.euf.2017.12.005. Epub 2018 Jan 3.
4
Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.2014年国际泌尿病理学会前列腺癌分级系统对接受根治性前列腺切除术患者的预测价值及长期随访
BJU Int. 2017 Nov;120(5):651-658. doi: 10.1111/bju.13857. Epub 2017 Apr 30.
5
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.
6
Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.在局限性前列腺癌中,根治性前列腺切除术标本中的三级Gleason分级模式与下一个更高Gleason评分组相比,预后更差。
Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.
7
Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.当代前列腺癌 Gleason 模式 4 的百分比和结构类型对根治性前列腺切除术预后的意义。
Am J Surg Pathol. 2016 Oct;40(10):1400-6. doi: 10.1097/PAS.0000000000000691.
8
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.淋巴结阳性前列腺癌根治术后临床复发模式的自然史。
Eur Urol. 2016 Jan;69(1):135-42. doi: 10.1016/j.eururo.2015.03.036. Epub 2015 Apr 10.
9
LONG-TERM RADICAL PROSTATECTOMY ONCOLOGIC OUTCOMES IN PATIENTS WITH CLINICALLY LOCALLY ADVANCED PROSTATE CANCER: A SINGLE-CENTER STUDY.临床局部晚期前列腺癌患者长期根治性前列腺切除术的肿瘤学结局:一项单中心研究。
Exp Oncol. 2022 May;44(1):67-74. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-1.17436.
10
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

引用本文的文献

1
Multi-Omics Analysis of the Anoikis Gene in Prostate Cancer and Biochemical Recurrence (BCR).前列腺癌中失巢凋亡基因与生化复发(BCR)的多组学分析
Biomedicines. 2025 Mar 7;13(3):661. doi: 10.3390/biomedicines13030661.
2
A Multi-Omics-Based Exploration of the Predictive Role of MSMB in Prostate Cancer Recurrence: A Study Using Bayesian Inverse Convolution and 10 Machine Learning Combinations.基于多组学探索MSMB在前列腺癌复发中的预测作用:一项使用贝叶斯反卷积和10种机器学习组合的研究
Biomedicines. 2025 Feb 16;13(2):487. doi: 10.3390/biomedicines13020487.

本文引用的文献

1
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.高危和极高危前列腺癌患者根治性前列腺切除术后与放射治疗后的生存率比较
J Urol. 2022 Feb;207(2):375-384. doi: 10.1097/JU.0000000000002250. Epub 2021 Sep 24.
2
Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korea.在韩国,局限性前列腺癌根治性前列腺切除术后的长期肿瘤学结果:10 年随访。
Investig Clin Urol. 2020 May;61(3):269-276. doi: 10.4111/icu.2020.61.3.269. Epub 2020 Apr 21.
3
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
根治性前列腺切除术和放疗后局部前列腺癌的生存和并发症:国际协作回顾。
Eur Urol. 2018 Jan;73(1):11-20. doi: 10.1016/j.eururo.2017.05.055. Epub 2017 Jun 11.
4
Natural history of early, localized prostate cancer: a final report from three decades of follow-up.早期局限性前列腺癌自然史:三十余年随访的最终报告。
Eur Urol. 2013 Mar;63(3):428-35. doi: 10.1016/j.eururo.2012.10.002. Epub 2012 Oct 13.
5
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.根治性前列腺切除术治疗 cT3 前列腺癌 20 年生存。
BJU Int. 2012 Dec;110(11):1709-13. doi: 10.1111/j.1464-410X.2012.11372.x. Epub 2012 Aug 30.
6
Time trends and local variation in primary treatment of localized prostate cancer.局限性前列腺癌的主要治疗方法的时间趋势和局部变化。
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
7
Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute.腹腔镜前列腺癌根治术:中国一家机构对126例患者进行至少3年随访的肿瘤学及功能学结果
Asian J Androl. 2009 Sep;11(5):548-56. doi: 10.1038/aja.2009.42. Epub 2009 Aug 3.
8
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.25年前列腺癌控制与生存结果:一项40年单机构根治性前列腺切除术系列研究
J Urol. 2006 Aug;176(2):569-74. doi: 10.1016/j.juro.2006.03.094.